Euclidean Technologies Management’s CVS Health CVS Stock Holding History

Euclidean Technologies Management’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-2,289	Closed	-$236K	–	85
2021 Q4	$236K	Buy	+2,289	New	+$212K	0.2%	70
2019 Q1	–	Sell	-19,055	Closed	-$1.25M	–	69
2018 Q4	$1.25M	Sell	19,055 -15,178	-44%	-$1.13M	1.3%	41
2018 Q3	$2.69M	Hold	34,233	–	–	2.38%	3
2018 Q2	$2.2M	Buy	34,233 +19,055	+126%	+$1.26M	2.05%	16
2018 Q1	$944K	Sell	15,178 -4,029	-21%	-$289K	0.93%	59
2017 Q4	$1.39M	Sell	19,207 -200	-1%	-$14.5K	1.37%	49
2017 Q3	$1.58M	Sell	19,407 -7,600	-28%	-$601K	1.51%	41
2017 Q2	$2.17M	Buy	27,007 +8,141	+43%	+$643K	2.1%	19
2017 Q1	$1.48M	Buy	+18,866	New	+$1.51M	1.37%	44

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Euclidean Technologies Management's CVS Position: Q1 2022 in Review

Euclidean Technologies Management sold out of CVS Health (CVS) in Q1 2022, closing a stake of 2,289 shares — an estimated $236K sold.

Euclidean Technologies Management first reported a position in CVS in Q1 2017 and held it in 9 quarters. The position peaked at $2.69M in Q3 2018. 2,365 funds tracked by Wall St. Rank hold CVS as of Q1 2022.

Euclidean Technologies Management reported no remaining CVS Health position as of Q1 2022 after selling out during the quarter.
Euclidean Technologies Management sold 2,289 CVS Health shares in Q1 2022, an estimated $236K.
Euclidean Technologies Management first reported a position in CVS Health in Q1 2017 and held it in 9 quarters.
Euclidean Technologies Management's CVS Health position peaked at $2.69M in Q3 2018.
2,365 funds tracked by Wall St. Rank held CVS Health as of Q1 2022.

Based on Euclidean Technologies Management's 13F filing for Q1 2022, filed 28 Apr 2022.